Lyell Immunopharma
Price & Volume
Stats
See moreOpen | $0.67 |
Previous Close | $0.66 |
Day Range | $0.67-$0.72 |
52W Range | $0.50-$3.25 |
Market Cap | $180.7M |
Shares Short | 11M |
Financials
See moreRevenue (12 Mos) | $63,000 |
Revenue Growth (YoY) | 36% |
Gross Profit (12 Mos) | $63,000 |
Diluted EPS | -$0.79 |
News
See moreYahoo Finance • last year
Lyell Immunopharma Receives FDA Orphan Drug Designation for LYL845 for the Treatment of Melanoma
Yahoo Finance • last year
Lyell Immunopharma Reports Business Highlights and Financial Results for the Third Quarter 2023
Yahoo Finance • last year
Lyell Immunopharma Announces the Acceptance of Six Abstracts for Presentation at 2023 Society for Immunotherapy of Cancer (SITC) Annual Meeting
Yahoo Finance • last year
Lyell Immunopharma to Participate in Upcoming Investor Conferences
About
CEO | Dr. Lynn Seely M.D., Ph.D. |
Address | 201 Haskins Way, South San Francisco, CA, United States, 94080 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 224 |
